EP2470542A4 - Préparation de la sitagliptine et de ses sels - Google Patents

Préparation de la sitagliptine et de ses sels

Info

Publication number
EP2470542A4
EP2470542A4 EP10812650.9A EP10812650A EP2470542A4 EP 2470542 A4 EP2470542 A4 EP 2470542A4 EP 10812650 A EP10812650 A EP 10812650A EP 2470542 A4 EP2470542 A4 EP 2470542A4
Authority
EP
European Patent Office
Prior art keywords
sitagliptin
salts
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10812650.9A
Other languages
German (de)
English (en)
Other versions
EP2470542A2 (fr
Inventor
Rakeshwar Bandichhor
Nagaraju Gudimalla
Namrata Dwivedi
Kiran Kumar Chetluru
Srinivas Reddy Gade
Venkateswarlu Muvva
Bindu Srivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of EP2470542A2 publication Critical patent/EP2470542A2/fr
Publication of EP2470542A4 publication Critical patent/EP2470542A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP10812650.9A 2009-08-28 2010-08-27 Préparation de la sitagliptine et de ses sels Withdrawn EP2470542A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2090CH2009 2009-08-28
US31090010P 2010-03-05 2010-03-05
PCT/US2010/046938 WO2011025932A2 (fr) 2009-08-28 2010-08-27 Préparation de la sitagliptine et de ses sels

Publications (2)

Publication Number Publication Date
EP2470542A2 EP2470542A2 (fr) 2012-07-04
EP2470542A4 true EP2470542A4 (fr) 2013-04-24

Family

ID=43628673

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10812650.9A Withdrawn EP2470542A4 (fr) 2009-08-28 2010-08-27 Préparation de la sitagliptine et de ses sels

Country Status (2)

Country Link
EP (1) EP2470542A4 (fr)
WO (1) WO2011025932A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102838603B (zh) * 2011-06-24 2015-05-13 上海医药工业研究院 一种西他列汀的中间体化合物的制备方法
US20150025080A1 (en) 2011-06-29 2015-01-22 Ranbaxy Laboratories Limited Solid dispersions of sitagliptin and processes for their preparation
CA2840806A1 (fr) 2011-06-30 2013-01-03 Ranbaxy Laboratories Limited Nouveaux sels de sitagliptine
WO2013065066A1 (fr) * 2011-11-02 2013-05-10 Cadila Healthcare Limited Procédés de préparation de 4-oxo-4-[3-(trifluorométhyl)-5,6-dihydro- [l,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophényl)- butan-2-amine
US20140350023A1 (en) 2011-12-08 2014-11-27 Ranbaxy Laboratories Limited Amorphous form of sitagliptin salts
EP2674432A1 (fr) 2012-06-14 2013-12-18 LEK Pharmaceuticals d.d. Nouvelle voie de synthèse pour la préparation de composés à substitution ß-aminobutyryle 5,6,7,8-tétrahydro[1,4]diazolo[4,3-alpha]pyrazines-7-yl
CN104447753B (zh) * 2013-09-17 2017-03-29 深圳翰宇药业股份有限公司 一种西他列汀及其中间体的制备方法
SI3102187T1 (sl) 2014-02-03 2020-08-31 Galenicum Health S.L. Stabilne farmacevtske sestave, ki vsebujejo sitagliptin v obliki tablet s takojšnjim sproščanjem
US9938282B2 (en) * 2014-02-05 2018-04-10 Stereokem, Inc. Expedient synthesis of sitagliptin
WO2015162506A1 (fr) 2014-04-21 2015-10-29 Suven Life Sciences Limited Procédé de préparation de sitagliptine et nouveaux intermédiaires
CN116675695A (zh) * 2023-06-02 2023-09-01 江苏八巨药业有限公司 一种化学酶法合成西他列汀中间体的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004085661A2 (fr) * 2003-03-24 2004-10-07 Merck & Co., Inc Procede de synthese de derives d'acides amines beta chiraux
WO2009085990A2 (fr) * 2007-12-20 2009-07-09 Dr. Reddy's Laboratories Limited Procédés de préparation de sitagliptine et sels pharmaceutiquement acceptables de celle-ci

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004085661A2 (fr) * 2003-03-24 2004-10-07 Merck & Co., Inc Procede de synthese de derives d'acides amines beta chiraux
WO2009085990A2 (fr) * 2007-12-20 2009-07-09 Dr. Reddy's Laboratories Limited Procédés de préparation de sitagliptine et sels pharmaceutiquement acceptables de celle-ci

Also Published As

Publication number Publication date
WO2011025932A3 (fr) 2011-07-21
WO2011025932A2 (fr) 2011-03-03
EP2470542A2 (fr) 2012-07-04

Similar Documents

Publication Publication Date Title
EP2470542A4 (fr) Préparation de la sitagliptine et de ses sels
IL215315A0 (en) Solid state forms of sitagliptin salts
EP2464227A4 (fr) Composés et leurs procédés d utilisation
ZA201303586B (en) Salts and crystalline forms of an apoptosis-inducing agent
IL219974A0 (en) Therapeutic compounds and related methods of use
ZA201107592B (en) Salt of abt-263 and solid-state forms thereof
PL2571863T3 (pl) Sole nilotynibu i ich postacie krystaliczne
EP2358658A4 (fr) Préparation de rasagiline et de ses sels
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
EP2516404A4 (fr) Préparation de la bendamustine et de ses sels
EP2702034A4 (fr) Préparation du fingolimod et ses sels
PL2427417T3 (pl) Sole kwasu 3-pentylofenylooctowego i ich farmaceutyczne zastosowania
ZA201209666B (en) Salts and polymorhs of dexrabeprazole
EP2563768A4 (fr) Préparation of fébuxostat
EP2265586A4 (fr) Préparation de montélukast et ses sels
EP2581369A4 (fr) Procédé de préparation de dronédarone et de ses sels
PL2501380T3 (pl) Powolny wlew sulkardyny i jej soli
EP2601200A4 (fr) Préparation de chlorhydrate de prasugrel
IL222714A0 (en) Preparation of polypeptides and salts thereof
ZA201207945B (en) Salts of dexlansoprazole and their preparation
ZA201106884B (en) Process for the preparation of doxazosin and salts thereof
PL2513099T3 (pl) Wytwarzanie związków n-monofluoroalkilowych
PT2655363T (pt) Formas cristalinas e processos para a sua preparação
PL2547683T3 (pl) Sposób wytwarzania Sitagliptyny
EP2459540A4 (fr) Préparation du fipamézole

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120315

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20130325

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 487/04 20060101AFI20130319BHEP

Ipc: A61P 3/10 20060101ALI20130319BHEP

Ipc: A61K 31/4985 20060101ALI20130319BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131022